≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Unspecified chronic bronchitis

DOID EFO Endpoint Browser PheWeb

J10_BRONCHNAS

bronchitis: An acute or chronic inflammatory process affecting the bronchi. [database_cross_reference: NCIT:C2911]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J42
  • Hospital discharge: ICD-9 — 4919
  • Hospital discharge: ICD-8 — 49109
  • Cause of death: ICD-10 — J42
  • Cause of death: ICD-9 — 4919
  • Cause of death: ICD-8 — 49109

2 out of 7 registries used, show all original rules.

1533

4. Check minimum number of events

None

1533

5. Include endpoints

None

1533

6. Filter based on genotype QC (FinnGen only)

1533

Control definitions (FinnGen only)

Control exclude
J10_LOWCHRON

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
J40-J47
Name in latin
Bronchitis chronica non specificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 18442 6735 11129
Only index persons 8641 4155 4486
Unadjusted period prevalence (%)
Whole population 0.28 0.19 0.31
Only index persons 0.16 0.15 0.17
Median age at first event (years)
Whole population 61.97 59.69 63.16
Only index persons 54.81 54.34 55.24

-FinnGen-

Key figures

All Female Male
Number of individuals 1533 567 966
Unadjusted period prevalence (%) 0.34 0.19 0.43
Median age at first event (years) 57.22 53.52 59.40

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1419
Matched controls
14185
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
106.5
323.0
472
66
J45.9
ICD-10 Finland
Asthma, unspecified
59.7
323.0
417
98
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
323.0
530
*
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
+∞
323.0
317
*
J42
ICD-10 Finland
Unspecified chronic bronchitis
1661.3
323.0
952
18
R03BB04
ATC
tiotropium bromide; inhalant
26.3
264.4
378
193
R03AC02
ATC
salbutamol; inhalant
7.1
252.3
947
3115
R03AK06
ATC
salmeterol and fluticasone; inhalant
15.2
206.0
362
313
R03DA04
ATC
theophylline; systemic, rectal
22.8
194.9
290
158
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
17.8
194.3
317
225
4919X
ICD-9 Finland
Chronic bronchitis, Unspecified chronic bronchitis
+∞
188.8
177
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
100.8
176.3
192
22
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
381.3
172.3
170
5
H02AB06
ATC
prednisolone; systemic
4.7
159.8
856
3481
R03BA02
ATC
budesonide; inhalant
9.2
157.6
360
503
R03BA05
ATC
fluticasone; inhalant
8.3
155.2
382
602
J45.1
ICD-10 Finland
Nonallergic asthma
285.3
152.6
153
6
R03BB01
ATC
ipratropium bromide; inhalant
17.8
152.0
246
165
R03AC12
ATC
salmeterol; inhalant
58.0
151.0
178
35
R03BA01
ATC
beclometasone; inhalant
9.7
143.7
316
408
J45.0
ICD-10 Finland
Predominantly allergic asthma
144.3
135.9
143
11
UGC12
NOMESCO Finland
Flexible bronchoscopy
8.6
131.2
309
443
R03AK07
ATC
formoterol and budesonide; inhalant
7.2
127.1
343
603
R03DC03
ATC
montelukast; oral
9.2
124.3
280
370
J47
ICD-10 Finland
Bronchiectasis
646.3
122.1
119
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
286.4
105.3
106
*
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
+∞
99.1
94
*
R03AC13
ATC
formoterol; inhalant
34.7
92.7
121
38
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.4
89.9
382
1096
49300
ICD-8 Finland
Asthma, bronchiale
+∞
83.1
79
*
R03AC03
ATC
terbutaline; inhalant
6.1
81.4
241
459
H02AB04
ATC
methylprednisolone; systemic
4.7
79.2
306
788
R03BA08
ATC
ciclesonide; inhalant
11.5
77.6
150
144
J45.8
ICD-10 Finland
Mixed asthma
120.9
74.7
80
7
J01AA02
ATC
doxycycline; systemic
3.1
73.7
1128
7846
R05
ICD-10 Finland
Cough
3.8
71.5
357
1155
J45
ICD-10 Finland
Asthma
14.7
71.0
122
90
J01FA06
ATC
roxithromycin; oral
2.8
69.2
639
3199
R03AK08
ATC
formoterol and beclometasone; inhalant
52.8
67.0
80
16
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
65.0
547
2557
R96
ICPC
Asthma
12.3
64.4
120
106
J01MA14
ATC
moxifloxacin; systemic
5.3
64.2
212
453
R06.0
ICD-10 Finland
Dyspnoea
3.1
61.9
428
1744
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
+∞
61.9
59
*
J46
ICD-10 Finland
Status asthmaticus
320.9
60.8
61
*
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
+∞
59.8
57
*
49099
ICD-8 Finland
Bronchitis, unspecified
+∞
58.7
56
*
H02AB07
ATC
prednisone; oral
3.7
55.1
277
882
J96.1
ICD-10 Finland
Chronic respiratory failure
21.1
53.7
80
40
R04.2
ICD-10 Finland
Haemoptysis
8.8
51.8
115
141
J01FA09
ATC
clarithromycin; systemic
2.7
51.4
445
2050
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
7.4
50.0
124
181
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
134.8
49.1
52
*
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
+∞
48.2
46
*
R03BB02
ATC
oxitropium bromide; inhalant
58.2
47.8
56
10
XG474
NOMESCO Finland
Exhalation nntrogen oxide
21.6
44.8
66
32
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
20.2
42.6
64
33
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.6
42.2
207
636
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
151.2
42.0
44
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
41.5
227
758
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
216.1
41.1
42
*
R95
ICPC
Chron obstructive pulmonary disease
22.7
40.8
59
27
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
39.8
627
3803
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.3
38.9
107
180
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
14.4
38.6
66
48
R06.2
ICD-10 Finland
Wheezing
8.0
36.6
85
112
J01FA10
ATC
azithromycin; systemic
2.1
36.5
664
4230
J01MA12
ATC
levofloxacin; systemic
2.5
35.6
324
1490
XG410
NOMESCO Finland
Flow-volume spirometry
7.3
35.5
88
128
J41.0
ICD-10 Finland
Simple chronic bronchitis
80.2
35.0
39
5
J01DA01
ATC
[U] cefalexin; systemic
2.0
34.6
880
6351
49101
ICD-8 Finland
Chronic bronchitis, Nonpurulenta (simplex)
+∞
34.5
33
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.7
33.2
73
88
R03AK11
ATC
formoterol and fluticasone; inhalant
21.5
32.8
48
23
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
32.2
401
2142
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
5.8
31.4
92
168
51899
ICD-8 Finland
Bronchiectasis
+∞
30.3
29
*
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
+∞
30.3
29
*
R01AD08
ATC
fluticasone; nasal
2.3
30.3
337
1700
R03DA05
ATC
aminophylline; systemic, rectal
25.4
30.2
42
17
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.1
30.0
439
2499
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
19.3
29.7
45
24
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
9.5
29.3
61
67
R05CB01
ATC
acetylcysteine; inhalant, oral
8.4
27.5
61
75
R03DC01
ATC
zafirlukast; oral
20.1
27.5
41
21
R02
ICPC
Shortness of breath/dyspnoea
3.0
27.1
168
605
J43.9
ICD-10 Finland
Emphysema, unspecified
61.2
26.0
30
5
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.0
25.7
106
278
R03BC03
ATC
nedocromil; inhalant
3.9
25.3
110
302
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
26.7
24.9
34
13
R05DA20
ATC
opium alkaloids and derivatives - combinations
2.1
24.6
337
1839
R01AD09
ATC
mometasone; nasal
1.9
24.1
480
3023
J01FA15
ATC
telithromycin; oral
3.0
24.0
144
507
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
9.2
23.9
50
56
49102
ICD-8 Finland
Chronic bronchitis, Purulenta
+∞
23.0
22
*
C03CA01
ATC
furosemide; systemic
1.8
22.5
540
3605
A02BC01
ATC
omeprazole; systemic
1.9
22.3
409
2488
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
+∞
21.9
21
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.8
21.8
62
110
48609
ICD-8 Finland
Pneumonia, unspecified
8.0
21.6
49
63
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
50.8
21.2
25
5
A02BA02
ATC
ranitidine; systemic
2.0
20.9
319
1803
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
20.9
214
1018
4910A
ICD-9 Finland
Chronic bronchitis, Simple chronic bronchitis
+∞
20.9
20
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
30.5
20.6
27
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
20.3
557
3844
G47.3
ICD-10 Finland
Sleep apnoea
2.1
20.3
249
1289
R05FB02
ATC
cough suppressants and expectorants
1.7
20.2
527
3583
N02AX02
ATC
tramadol; systemic, rectal
1.7
20.1
561
3888
R03AC04
ATC
fenoterol; inhalant
74.5
19.7
22
*
A01AB09
ATC
miconazole; local oral
2.7
18.9
137
543
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
+∞
18.8
18
*
XQ800
NOMESCO Finland
Prick test
3.9
18.6
77
204
R05CB02
ATC
bromhexine; systemic
5.7
18.4
53
96
1240
FHL
Bronchoscopy
6.8
18.2
46
70
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.4
18.0
88
268
4900A
ICD-9 Finland
Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]
+∞
17.7
17
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.3
17.7
54
105
R05
ICPC
Cough
2.0
17.6
243
1313
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
21.2
17.3
25
12
R29
ICPC
Respiratory symptom/complaint other
3.4
16.9
82
248
J20
ICD-10 Finland
Acute bronchitis
2.7
16.9
119
464
TGC00
NOMESCO Finland
Bronchial lavation
5.0
16.9
54
111
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.7
16.7
48
87
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.5
16.5
78
231
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.3
16.5
86
275
R03AC18
ATC
indacaterol; inhalant
40.6
16.3
20
5
A02BC05
ATC
esomeprazole; systemic
1.7
16.1
480
3333
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
16.0
411
2737
J31.0
ICD-10 Finland
Chronic rhinitis
3.1
15.7
89
300
SPAT1059
SPAT
Spirometry at the office
3.7
15.7
68
188
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
6.1
15.7
42
70
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
+∞
15.6
15
*
A02BC03
ATC
lansoprazole; oral
1.7
15.6
391
2578
J01DA06
ATC
[U] cefuroxime; systemic
2.1
15.6
183
922
C01AA05
ATC
digoxin; systemic
2.0
15.4
200
1052
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.0
15.3
62
162
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
6.3
15.2
40
65
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
15.1
57
139
SPAT1058
SPAT
PEF monitoring instruction
3.0
15.0
87
300
A02BC02
ATC
pantoprazole; systemic
1.6
15.0
788
6290
Y3409
ICD-8 Finland
Follow-up examination of illness, accident or surgery, Treated inactive pulmonary tuberculosis
32.0
14.8
19
6
XG460
NOMESCO Finland
Short time oxymetry
5.7
14.7
42
76
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
9.0
14.5
30
34
R03CC02
ATC
salbutamol; systemic
4.3
14.4
53
127
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
5.1
14.4
45
91
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
42.9
14.1
17
*
R01AD11
ATC
triamcinolone; nasal
2.5
14.0
108
444
Y0499
ICD-8 Finland
Investigation of respiratory system
6.3
13.8
36
58
R51.80
ICD-10 Finland
Headache
2.2
13.8
144
689
R05FA02
ATC
opium derivatives and expectorants; systemic
1.6
13.8
484
3480
48509
ICD-8 Finland
Bronchopneumonia, unspecified
7.4
13.8
32
44
J01CA04
ATC
amoxicillin; systemic
1.5
13.6
921
7721
4911A
ICD-9 Finland
Chronic bronchitis, Mucopurulent chronic bronchitis
+∞
13.6
13
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
13.2
116
511
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
13.2
250
1504
A07AA02
ATC
nystatin; oral
2.7
13.1
93
364
J37.0
ICD-10 Finland
Chronic laryngitis
4.3
13.1
48
115
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
50.4
12.9
15
*
R01AD12
ATC
fluticasone furoate; nasal
1.8
12.8
255
1557
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
5.9
12.7
35
61
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.9
12.6
75
264
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
+∞
12.5
12
*
49309
ICD-8 Finland
Asthma, Unspecified
+∞
12.5
12
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
12.5
250
1529
N05CD07
ATC
temazepam; oral
1.8
12.3
228
1359
A01AB04
ATC
amphotericin B; local oral
2.8
12.3
80
297
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.4
12.3
109
482
N05CF01
ATC
zopiclone; oral
1.6
12.1
453
3281
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
5.5
12.1
35
65
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
12.1
330
2204
C08DA01
ATC
verapamil; systemic
2.9
12.1
74
265
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
18.2
12.1
18
10
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.6
12.0
53
150
SPAT1263
SPAT
Sampling
1.5
12.0
486
3591
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
11.9
63
206
XG405
NOMESCO Finland
Education on PEF monitoring
9.3
11.5
23
25
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
11.2
320
2162
J01FA01
ATC
erythromycin; systemic
2.0
11.2
145
760
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
11.1
354
2457
J32.4
ICD-10 Finland
Chronic pansinusitis
10.1
11.0
21
21
C07AB07
ATC
bisoprolol; oral
1.5
10.9
637
5058
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
10.9
95
417
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
4.3
10.9
39
92
N03AX12
ATC
gabapentin; oral
1.9
10.7
173
983
M03BC51
ATC
orphenadrine, combinations; systemic
1.6
10.6
283
1874
J01FF01
ATC
clindamycin; systemic
1.6
10.6
302
2038
UDC00
NOMESCO Finland
Ear microscopy
2.3
10.5
95
424
Q32.21
ICD-10 Finland
Secondary congenital bronchomalacia
110.8
10.4
11
*
R03CC03
ATC
terbutaline; systemic
6.9
10.4
25
37
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
12.1
10.3
18
15
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
10.3
124
628
R09.3
ICD-10 Finland
Abnormal sputum
8.3
10.3
22
27
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
6.1
10.3
27
45
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
23.5
10.2
14
6
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
7.5
10.2
23
31
R05DA01
ATC
ethylmorphine; oral
2.2
10.1
103
489
R74
ICPC
Upper respiratory infection acute
1.7
10.1
224
1411
R06AE07
ATC
cetirizine; oral
1.5
10.0
421
3104
N06AA09
ATC
amitriptyline; systemic
2.0
10.0
126
653
N05BA04
ATC
oxazepam; oral
1.6
10.0
313
2158
J02AC01
ATC
fluconazole; systemic
1.5
9.9
372
2676
XG466
NOMESCO Finland
Sleep oxymetry
3.6
9.8
43
123
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.8
9.5
172
1015
R06AX13
ATC
loratadine; oral
1.9
9.5
138
755
E66.01
ICD-10 Finland
Obesity due to excess calories
2.6
9.4
67
264
P01AB01
ATC
metronidazole; oral, rectal
1.5
9.4
415
3085
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
+∞
9.4
9
*
N03AX16
ATC
pregabalin; oral
1.6
9.3
251
1664
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
9.3
293
2021
WZC30
NOMESCO Finland
Teaching
1.9
9.3
147
829
Z72.0
ICD-10 Finland
Tobacco use
4.4
9.2
32
74
R81
ICPC
Pneumonia
3.3
9.2
45
140
R28
ICPC
Limited function/disability (R)
7.3
9.2
21
29
R01AD01
ATC
beclometasone; nasal
1.8
9.1
153
879
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
15.7
9.0
14
9
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
3.2
9.0
46
148
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
9.0
386
2851
R06.5
ICD-10 Finland
Mouth breathing
2.2
8.9
92
438
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
8.9
382
2819
UJF32
NOMESCO Finland
Coloscopy
1.5
8.9
302
2119
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
8.7
8.8
18
21
48601
ICD-8 Finland
More specifically, unspecified pneumonia and the pleural irritation caused by it
10.8
8.8
16
15
M54.5
ICD-10 Finland
Low back pain
1.5
8.7
320
2283
J01DC02
ATC
cefuroxime; systemic
2.5
8.7
64
260
R49.01
ICD-10 Finland
Functional dysphonia
3.7
8.7
36
99
R52.2
ICD-10 Finland
Other chronic pain
3.4
8.6
40
120
N05BA01
ATC
diazepam; systemic, rectal
1.7
8.6
174
1062
R05CB03
ATC
carbocisteine; oral
3.5
8.6
38
110
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.4
8.6
40
121
78310
ICD-8 Finland
Symptoms referable to respiratory system, Haemoptysis
9.0
8.5
17
19
R01AD05
ATC
budesonide; nasal
2.3
8.5
74
326
A02BA03
ATC
famotidine; systemic
2.4
8.5
71
307
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
6.0
8.5
22
37
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
7.4
8.4
19
26
N06AB04
ATC
citalopram; systemic
1.6
8.4
248
1678
J43.8
ICD-10 Finland
Other emphysema
90.5
8.4
9
*
R11
ICD-10 Finland
Nausea and vomiting
2.1
8.4
97
487
J01DA08
ATC
[U] cefaclor; oral
2.1
8.4
95
474
A02BA04
ATC
nizatidine; systemic
1.9
8.3
119
645
J41.8
ICD-10 Finland
Mixed simple and mucopurulent chronic bronchitis
+∞
8.3
8
*
G44.2
ICD-10 Finland
Tension-type headache
1.9
8.2
116
629
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
8.2
112
601
L03
ICPC
Low back symptom/complaint
1.6
8.1
235
1583
7863A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Haemoptysis
9.0
8.0
16
18
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.7
8.0
51
190
J15.8
ICD-10 Finland
Other bacterial pneumonia
7.3
8.0
18
25
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.9
8.0
46
161
R06AX27
ATC
desloratadine; oral
1.6
7.9
213
1408
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.5
7.8
57
229
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
7.8
252
1742
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
7.7
92
467
A06AD11
ATC
lactulose; oral
1.6
7.7
237
1617
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
5.3
7.7
22
42
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
10.1
7.5
14
14
A03CA02
ATC
clidinium and psycholeptics; oral
2.0
7.5
88
444
R03AC19
ATC
olodaterol; inhalant
80.5
7.4
8
*
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
6.5
7.4
18
28
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.3
7.4
35
108
51925
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis NUD
6.0
7.4
19
32
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
7.3
179
1153
4939A
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]
+∞
7.3
7
*
J43.2
ICD-10 Finland
Centrilobular emphysema
+∞
7.3
7
*
M04AA01
ATC
allopurinol; systemic
1.6
7.3
195
1287
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
7.2
458
3615
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
7.2
322
2383
R07.3
ICD-10 Finland
Other chest pain
1.9
7.2
106
583
N06AX21
ATC
duloxetine; oral
1.9
7.1
100
541
D07AC13
ATC
mometasone; topical
1.5
7.1
312
2299
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
3.1
7.1
36
117
J01MA02
ATC
ciprofloxacin; systemic
1.4
7.1
489
3914
C03DA01
ATC
spironolactone; oral
1.7
7.0
143
879
50300
ICD-8 Finland
Chronic sinusitis, Maxillaris cum empyemate
6.4
6.9
17
27
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.9
6.9
91
483
E66.00
ICD-10 Finland
Metabolic syndrome
2.4
6.9
53
222
R78
ICPC
Acute bronchitis/bronchiolitis
3.6
6.9
29
82
GD1AA
SPAT
NA
2.4
6.8
57
246
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
6.8
107
603
N06AA12
ATC
doxepin; systemic
2.1
6.8
77
386
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
5.3
6.8
19
36
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
6.7
156
993
D72.1
ICD-10 Finland
Eosinophilia
22.6
6.7
9
*
M01AE02
ATC
naproxen; oral, rectal
1.3
6.6
600
5006
30180
ICD-8 Finland
Personality disorders, Immatura
12.3
6.6
11
9
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.8
6.6
26
70
WX723
NOMESCO Finland
CPAP therapy
2.9
6.6
38
134
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
10.1
6.5
12
12
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.2
6.5
61
281
Z01.9
ICD-10 Finland
Special examination, unspecified
2.2
6.5
65
307
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
70.1
6.4
7
*
R03BB05
ATC
aclidinium bromide; inhalant
70.1
6.4
7
*
J98.1
ICD-10 Finland
Pulmonary collapse
7.4
6.4
14
19
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
6.4
74
373
R04
ICPC
Breathing problem other
2.8
6.4
38
138
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
6.4
105
602
C08DB01
ATC
diltiazem; oral
1.8
6.4
103
585
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.4
326
2472
ZX140
NOMESCO Finland
Intra articular
8.2
6.3
13
16
R05DB05
ATC
pentoxyverine; oral, rectal
2.4
6.3
51
218
N06AX03
ATC
mianserin; oral
2.2
6.3
60
280
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
6.3
99
560
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
3.9
6.3
24
63
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.7
6.3
120
724
J14
ICD-10 Finland
Pneumonia due to Haemophilus influenzae
+∞
6.3
6
*
4939B
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]
+∞
6.3
6
*
5191A
ICD-9 Finland
Other diseases of respiratory system, Other diseases of trachea and bronchus, not elsewhere classified
+∞
6.3
6
*
348
Kela drug reimbursment
Roflumilast
+∞
6.3
6
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.4
6.2
28
84
M79.6
ICD-10 Finland
Pain in limb
1.4
6.2
344
2638
51900
ICD-8 Finland
Other diseases of respiratory system, Atelectasis pulmonis
26.8
6.2
8
*
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
2.3
6.2
56
254
N06AX11
ATC
mirtazapine; oral
1.4
6.2
331
2523
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
2.2
6.2
61
288
M03BX02
ATC
tizanidine; oral
1.3
6.2
594
4984
R05DB20
ATC
other cough suppressants - combinations
2.1
6.2
68
337
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.1
6.2
63
302
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
6.1
173
1155
S82.4
ICD-10 Finland
Fracture of fibula alone
4.2
6.1
21
50
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
4.2
6.1
21
50
5645A
ICD-9 Finland
Functional digestive disorders, not elsewhere classified, Functional diarrhoea
12.6
6.1
10
8
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
6.1
44
180
M48.0
ICD-10 Finland
Spinal stenosis
1.6
6.1
145
930
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
3.1
6.0
31
103
D07XC01
ATC
betamethasone, combinations; topical
1.6
6.0
140
889

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023419) Bacteria identified in Sputum by Culture
126
66
20.71
163.08
3.7
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
185
330
6.24
101.15
1.7
1.1
u/ml
168.2
202.6
0.17
173
294
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
50
15
34.41
78.46
1.6
1.1
u/ml
2.5
0.0
—
29
5
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
63
38
17.24
75.75
4.6
2.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
90
126
7.52
61.44
4.0
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
117
321
3.86
37.41
3.2
2.6
—
—
—
0
0
(4062490)
47
59
8.18
35.08
1.4
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
46
58
8.14
34.21
1.3
1.4
g/l
2.8
2.5
0.47
30
37
(3024139) IgG subclass 3 [Mass/volume] in Serum
46
58
8.14
34.21
1.3
1.4
g/l
0.3
0.4
0.89
30
38
(3027135) IgG subclass 1 [Mass/volume] in Serum
46
58
8.14
34.21
1.3
1.4
g/l
7.2
7.8
0.27
30
38
(3015235) Bicarbonate [Moles/volume] in Capillary blood
94
240
4.11
33.16
3.3
2.6
mmol/l
25.0
24.4
0.63
75
205
(3013115) Eosinophils [#/volume] in Blood
728
4954
1.89
32.18
7.2
5.6
e9/l
0.2
0.2
1.47
653
4283
(3006504) Eosinophils/100 leukocytes in Blood
681
4542
1.90
31.97
7.3
5.6
%
2.8
2.8
0.08
632
4187
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
58
102
5.87
31.75
1.3
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
665
4412
1.90
31.64
7.2
5.7
%
0.6
0.7
0.30
622
4072
(3019069) Monocytes/100 leukocytes in Blood
678
4555
1.88
30.77
7.5
5.9
%
8.6
8.9
1.77
634
4219
(3005719) IgG [Mass/volume] in Serum or Plasma
172
675
2.74
30.32
2.9
2.8
g/l
10.9
11.2
0.25
158
611
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
49
78
6.45
29.62
4.8
3.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
527
3315
1.90
28.94
6.6
5.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
681
4664
1.83
28.37
7.4
5.8
%
25.6
27.0
2.49
640
4287
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
163
644
2.71
28.30
5.3
3.4
kpa
5.2
5.1
1.21
149
587
(3006315) Basophils [#/volume] in Blood
698
4820
1.82
28.27
6.9
5.4
e9/l
0.1
0.0
0.58
626
4094
(40760892) CBC W Ordered Manual Differential panel - Blood
360
2009
2.03
27.93
5.7
4.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
78
199
4.08
27.53
1.4
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
84
227
3.86
27.38
3.4
2.3
kpa
7.9
8.0
0.32
76
207
(3028026) IgM [Mass/volume] in Serum or Plasma
142
532
2.84
27.26
1.7
1.8
g/l
1.1
1.5
1.42
130
476
(3001604) Monocytes [#/volume] in Blood
689
4796
1.79
26.70
6.9
5.4
e9/l
0.6
0.6
3.42
617
4072
(3000492) Spirometry study
155
618
2.68
26.39
1.6
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
664
4585
1.79
26.33
7.1
5.6
%
59.4
57.9
2.34
625
4238
(3009343) pH of Capillary blood
157
636
2.64
25.89
5.3
3.4
ph
7.4
7.4
2.53
28
72
(3019198) Lymphocytes [#/volume] in Blood
699
4927
1.77
25.61
7.0
5.5
e9/l
2.1
1.9
0.30
634
4261
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
151
608
2.64
25.19
5.2
3.4
mmol/l
1.6
1.5
0.04
123
441
(3021901) Oxygen saturation in Capillary blood
70
178
4.07
24.82
2.8
2.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
19
10
19.22
23.95
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
50
106
4.84
22.29
1.4
1.3
g/l
0.8
0.7
0.13
34
79
(3002179) Metamyelocytes/100 leukocytes in Blood
158
726
2.31
19.72
3.9
4.1
%
0.8
0.6
0.40
34
191
(3000494) Fungus identified in Specimen by Culture
211
1101
2.06
19.12
1.9
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
61
172
3.65
18.73
3.4
3.0
e9/l
5.2
4.4
1.38
61
172
(4015189)
19
16
12.01
18.70
3.1
1.5
—
—
—
0
0
(4010399)
116
476
2.55
18.55
1.5
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
113
460
2.57
18.37
2.4
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
62
182
3.51
17.93
3.5
3.6
%
60.5
59.1
0.30
62
182
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
300
1803
1.82
17.78
2.5
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
744
5683
1.60
17.76
10.4
8.7
e9/l
4.5
4.1
4.26
673
4917
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
320
1996
1.76
16.63
2.5
1.6
mg/l
1.0
1.3
1.65
237
1546
(3012501) Base excess in Blood by calculation
70
234
3.09
16.45
7.1
4.6
mmol/l
2.4
2.6
0.27
51
149
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
58
173
3.44
16.39
1.4
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
156
775
2.13
16.01
4.3
4.3
%
0.1
0.1
0.01
46
250
(40767503) Oxygen content in Capillary blood by calculation
64
207
3.18
15.90
3.3
2.3
%
16.3
16.0
0.20
34
97
(3017181) Myelocytes/100 leukocytes in Blood
162
823
2.08
15.67
4.2
4.2
%
1.3
0.9
0.81
47
275
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
82
308
2.76
15.63
2.2
1.5
titre
175.6
147.5
—
9
16
(3037522) Nuclear Ab [Titer] in Serum
200
1098
1.94
15.57
1.4
1.3
titre
572.4
512.0
0.14
45
230
(1616796) Gas panel - Central venous blood
65
218
3.07
15.20
5.1
4.0
—
—
—
0
0
(3010421) pH of Blood
76
279
2.81
15.13
6.9
4.2
ph
7.4
7.4
1.21
68
227
(3025159) Blasts/100 leukocytes in Blood
145
716
2.13
15.10
4.3
4.4
%
0.2
0.2
0.02
35
211
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
100
428
2.43
14.62
2.2
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
107
473
2.36
14.56
5.8
3.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
51
152
3.44
14.45
2.1
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
32
71
4.58
13.56
1.9
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
163
881
1.95
13.23
4.8
4.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
437
3123
1.56
12.87
5.3
4.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
75
306
2.52
12.17
2.4
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
53
181
3.00
12.06
1.2
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
120
3.48
11.98
2.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
197
1171
1.78
11.82
4.7
3.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
62
234
2.72
11.76
2.4
1.6
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
16
21
7.69
11.43
1.9
3.3
ug/l
34.9
348.6
0.45
16
21
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
44
140
3.21
11.29
2.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
214
1323
1.72
11.17
1.4
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
158
894
1.85
11.13
4.6
3.9
mmol/l
1.2
1.2
0.27
139
766
(3007853) Bacteria identified in Skin by Aerobe culture
192
1155
1.76
11.04
2.1
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
34
93
3.72
10.98
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
55
4.60
10.72
2.0
2.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
81
367
2.27
10.45
1.8
2.0
u/l
35.9
37.8
0.39
72
313
(3007164) IgA [Mass/volume] in Serum or Plasma
254
1678
1.62
10.22
1.6
1.4
g/l
2.5
2.5
0.03
171
977
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
39
124
3.20
10.04
2.4
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
30
81
3.76
9.89
1.8
2.0
e9/l
1.2
1.1
0.38
19
44
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
55
4.42
9.81
1.8
2.2
%
12.8
15.4
0.36
12
25
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
23
51
4.56
9.78
1.7
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
23
51
4.56
9.78
1.7
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
23
51
4.56
9.78
1.7
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
23
51
4.56
9.78
1.7
1.6
—
—
—
0
0
(3013512) EKG study
432
3238
1.46
9.66
4.8
3.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
704
8323
0.71
9.38
29.3
19.9
g/l
330.5
332.0
4.05
695
8214
(3036481) Cortisol [Moles/volume] in Serum or Plasma
144
835
1.80
9.36
2.3
2.1
nmol/l
324.1
385.7
4.22
123
751
(3042936) Bacteria identified in Isolate by Culture
228
1498
1.61
9.34
2.7
2.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
23
54
4.31
9.13
3.2
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
160
968
1.73
8.98
2.5
2.2
ug/g
152.0
134.3
0.28
117
771
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
41
145
2.88
8.84
2.1
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
54
225
2.45
8.46
2.6
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
235
1594
1.56
8.37
3.1
2.4
g/l
2.4
2.3
1.89
214
1458
(3018851) Theophylline [Moles/volume] in Serum or Plasma
8
0
+∞
8.34
1.9
0.0
umol/l
41.8
—
—
8
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
22
54
4.12
8.27
3.3
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
63
3.85
8.25
3.2
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
102
3.18
8.25
1.2
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
48
195
2.51
7.95
2.8
2.0
g/l
130.3
127.9
0.27
39
150
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
437
3387
1.41
7.87
4.5
3.0
ng/l
1552.0
1939.3
0.84
386
2907
(3013707) Erythrocyte sedimentation rate by Westergren method
865
7479
1.36
7.84
6.1
3.9
mm/h
15.3
13.6
2.29
810
6813
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
221
1508
1.54
7.64
3.2
2.4
%
18.9
22.7
5.43
196
1285
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
12
18
6.71
7.61
3.4
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
25
5.64
7.54
1.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
87
3.26
7.54
1.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
87
3.26
7.54
1.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
87
3.26
7.54
1.6
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
246
1732
1.50
7.33
3.2
2.4
umol/l
11.4
12.6
2.39
221
1586
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
31
105
2.99
7.25
3.0
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
537
4359
1.36
7.15
15.6
9.5
e9/l
0.0
0.0
1.47
457
3541
(3019060) Gas panel - Arterial blood
113
663
1.76
7.08
5.2
5.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
175
1154
1.58
7.02
1.6
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
729
6207
1.33
6.99
6.9
4.6
mmol/l
6.8
6.9
0.20
686
5817
(3008536) Aspergillus sp Ab [Presence] in Serum
11
17
6.51
6.78
2.4
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
21
58
3.66
6.75
2.0
2.0
e9/l
0.3
0.2
0.50
16
52
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
49
3.91
6.71
1.2
1.0
u/ml
14.0
0.8
—
8
14
(3000850) Epithelial cells [#/volume] in Urine
315
2365
1.42
6.67
3.2
2.6
e6/l
6.4
5.2
0.69
276
2089
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
412
3238
1.37
6.65
3.1
2.5
u/l
52.8
58.1
3.23
384
2966
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
178
2565
0.65
6.58
3.2
3.2
ug/l
0.8
0.9
0.77
124
1748
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
74
3.28
6.56
1.3
1.1
u/ml
5.0
1.4
—
10
25
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
521
4259
1.34
6.47
5.3
3.8
ng/l
69.9
62.8
0.14
378
3160
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
21
60
3.53
6.44
1.9
2.0
e6/l
478.1
702.2
0.61
15
52
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
41
173
2.41
6.32
2.9
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
34
131
2.63
6.32
1.6
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
125
781
1.65
6.25
2.0
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
34
132
2.61
6.23
1.6
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
804
9042
0.77
6.10
23.9
16.3
%
38.6
38.9
0.29
481
5963
(3017569) Oxygen content in Arterial blood
18
48
3.78
6.09
2.1
2.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
39
4.13
6.09
1.3
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
643
5460
1.31
5.97
7.1
6.1
umol/l
10.6
12.8
6.92
609
5165
(44813793)
16
40
4.03
5.90
1.1
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
29
107
2.74
5.87
1.3
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
205
1456
1.47
5.81
1.2
1.2
iu/ml
43.9
34.0
0.31
61
442
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
11
20
5.53
5.81
1.1
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
33
131
2.55
5.80
1.6
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
19
55
3.48
5.73
1.3
1.0
u/ml
3.7
4.2
—
8
12
(3023430) Cat dander IgE Ab [Units/volume] in Serum
17
46
3.72
5.65
1.2
1.1
u/ml
3.8
4.3
—
9
14
(3025941) Bacteria identified in Stool by Culture
85
495
1.76
5.52
1.4
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
29
4.51
5.51
1.5
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
195
1387
1.46
5.48
1.2
1.2
u/ml
5.2
12.3
1.54
80
519
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
33
135
2.48
5.47
3.0
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
57
294
1.97
5.40
1.6
1.4
ug/g
295.8
277.5
0.21
26
173
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
275
3545
0.73
5.37
4.2
4.5
%
22.7
22.1
0.24
134
1780
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
54
274
2.01
5.36
4.3
3.8
mg/l
1.8
1.7
0.12
47
250
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
179
1258
1.48
5.35
2.4
1.7
—
—
—
0
0
(3019225) pH of Specimen
159
1092
1.51
5.32
5.6
4.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
27
102
2.68
5.25
1.1
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
554
4672
1.29
5.24
5.9
4.7
g/l
34.6
35.0
0.70
511
4315
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
82
482
1.74
5.17
2.8
1.9
ug/l
1.5
3.1
0.75
68
414
(3032080) INR in Blood by Coagulation assay
538
4527
1.29
5.16
12.7
10.9
inr
1.3
1.4
1.09
215
1238
(3000963) Hemoglobin [Mass/volume] in Blood
1042
11238
0.77
5.10
35.5
22.3
g/l
133.4
133.7
0.20
1020
10973
(3007461) Platelets [#/volume] in Blood
1041
11228
0.77
5.09
35.1
22.2
e9/l
254.9
240.7
8.56
1020
10835
(3026361) Erythrocytes [#/volume] in Blood
1042
11234
0.77
5.05
35.0
22.2
e12/l
4.4
4.4
0.74
1017
10803
(3035941) MCH [Entitic mass]
1042
11233
0.77
5.04
34.8
22.1
pg
30.3
30.4
2.20
1023
10970
(3019977) pH of Arterial blood
17
50
3.43
5.03
1.9
3.3
ph
7.4
7.4
—
8
13
(3024731) MCV [Entitic volume]
1042
11232
0.77
5.03
34.9
22.1
fl
91.5
91.5
0.25
1023
10970
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
219
2.09
5.01
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
219
2.09
5.01
1.6
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
26
99
2.65
4.99
1.2
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
224
1663
1.41
4.99
5.0
3.1
mmol/l
0.8
0.8
1.92
206
1545
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
608
5218
1.27
4.92
3.1
2.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1044
11237
0.78
4.87
35.1
22.2
e9/l
7.7
6.7
2.03
1016
10801
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
145
998
1.50
4.81
3.8
2.9
ng/l
173.0
260.6
2.01
128
908
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
360
2894
1.32
4.80
2.6
2.1
mg/l
3.0
3.0
0.07
314
2412
(3014271) Vancomycin [Susceptibility]
21
73
2.90
4.77
3.1
3.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
31
132
2.38
4.75
1.6
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
79
2.81
4.72
3.7
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
965
10472
0.79
4.71
23.0
14.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
31
133
2.36
4.68
1.6
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
31
133
2.36
4.68
1.6
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
930
10129
0.79
4.64
5.3
5.0
mmol/l
2.7
2.7
0.06
821
9133
(3041096) Erythrocytes [Presence] in Urine by Automated
334
2669
1.32
4.63
4.5
3.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
220
1650
1.39
4.61
25.0
28.8
inr
1.2
1.4
2.49
80
224
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
44
220
2.03
4.59
1.5
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
5
14.05
4.57
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
64
2.99
4.56
1.1
1.0
u/ml
1.1
3.4
—
6
23
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
166
1189
1.44
4.51
9.6
7.1
kpa
5.3
5.0
3.43
156
1129
(3003396) Base excess in Arterial blood by calculation
166
1189
1.44
4.51
9.5
7.1
mmol/l
1.8
0.8
2.71
127
900
(3002385) Erythrocyte distribution width [Ratio]
732
8171
0.80
4.45
28.8
18.5
%
14.0
13.8
3.22
713
7953
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
90
1384
0.63
4.44
8.3
7.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
44
223
2.00
4.43
1.3
1.2
titre
201.4
67.1
—
7
17
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
305
2421
1.32
4.42
1.7
1.7
pmol/l
446.2
15290316.8
1.50
234
1949
(3026782) Osmolality of Urine
286
2250
1.33
4.41
3.2
2.8
mosm/kgh2o
517.7
563.8
3.45
249
1912
(3027801) Oxygen [Partial pressure] in Arterial blood
165
1188
1.44
4.36
9.6
7.1
kpa
10.5
12.3
6.71
155
1130
(3026493) Urate [Moles/volume] in Serum or Plasma
343
2777
1.30
4.30
3.0
2.8
umol/l
4118.2
7500.7
0.78
296
2363
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
616
5363
1.25
4.24
9.4
6.5
mmol/l
1.2
1.2
0.01
467
4461
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
172
1255
1.42
4.23
2.4
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
45
234
1.95
4.23
1.3
1.2
—
1395.0
—
0
6
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
23
4.37
4.09
1.4
2.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
14
42
3.35
4.04
1.1
1.0
u/ml
0.2
0.9
—
5
10
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
35
170
2.08
3.97
2.1
3.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
18
65
2.79
3.86
1.1
1.1
u/ml
8.3
4.9
—
7
27
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
174
1294
1.39
3.84
4.7
4.1
u/l
252.0
256.8
0.12
164
1206
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
15
6.03
3.81
2.7
1.3
ng/l
181.1
125.7
—
9
15
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
49
3.08
3.81
1.2
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
49
3.08
3.81
1.2
1.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
21
83
2.55
3.80
1.8
1.5
u/l
12.2
14.9
1.60
21
78
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
377
3143
1.26
3.70
3.6
3.2
u/l
33.0
36.2
0.51
351
2971
(3001122) Ferritin [Mass/volume] in Serum or Plasma
492
4229
1.24
3.69
3.3
2.7
ug/l
134.9
151.3
0.63
438
3818
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
37
680
0.53
3.63
1.8
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
26
3.86
3.52
1.3
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
916
9874
0.82
3.51
5.0
4.5
mmol/l
4.5
4.5
0.11
816
8972
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1011
10789
0.81
3.49
14.1
10.3
u/l
25.3
26.0
0.61
975
10295
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
80
521
1.56
3.48
12.9
9.2
mmol/l
25.1
24.1
2.11
72
481
(3016502) Oxygen saturation in Arterial blood
145
1070
1.39
3.37
10.4
7.5
%
93.5
95.8
2.17
139
1028
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
377
4426
0.80
3.36
5.3
5.1
ug/l
2.5
4.3
1.02
326
3903
(3002032) Base excess in Venous blood by calculation
138
1013
1.40
3.31
6.4
3.3
mmol/l
2.4
1.6
1.64
110
785
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
17
65
2.63
3.30
1.3
1.1
—
36.3
—
0
6
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
134
984
1.40
3.22
2.8
2.1
g/l
0.2
0.2
0.22
119
907
(3026008) Bacteria identified in Urine by Culture
394
3350
1.24
3.20
4.0
3.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94
647
1.48
3.19
2.0
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
454
0.48
3.11
1.6
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
912
9787
0.83
3.11
4.9
4.4
mmol/l
1.4
1.4
1.02
806
8812
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
99
2.24
3.06
1.1
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
138
1030
1.37
3.02
2.7
2.4
ug/l
8.8
7.1
0.16
113
880
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
81
2.36
2.99
1.4
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
40
3.01
2.97
2.1
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
40
3.01
2.97
2.1
1.7
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
33
176
1.89
2.96
1.5
1.2
u/ml
45.5
10.3
—
5
10
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
58
365
1.61
2.95
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
63
408
1.57
2.86
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
47
283
1.68
2.85
2.4
3.1
nmol/l
0.8
0.8
0.07
35
218
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
928
9904
0.84
2.80
5.2
4.7
mmol/l
6.1
6.0
0.47
824
8811
(3011397) Hemoglobin [Presence] in Urine by Test strip
187
2334
0.77
2.76
4.5
3.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
6
8.35
2.75
1.6
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
883
9455
0.84
2.73
4.5
4.0
mmol/l
1.4
1.3
3.30
776
8450
(3022145) Colonoscopy Study observation
141
1074
1.34
2.73
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
451
3945
1.20
2.71
2.1
2.3
—
—
—
0
0
(3000012) Reticulocyte production index
16
66
2.44
2.71
1.4
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
369
3166
1.22
2.71
4.4
4.0
ph
7.4
7.4
0.05
121
596
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
234
1.73
2.70
1.3
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
285
2383
1.24
2.68
1.9
1.8
nmol/l
1148.9
1164.4
0.10
199
1755
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
73
2.34
2.65
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
86
2.22
2.64
1.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
256
2120
1.25
2.62
5.5
3.8
ng/l
110.1
442.5
4.38
181
1758
(44790048)
22
107
2.07
2.57
1.4
1.5
—
—
—
0
0
(44790047)
22
107
2.07
2.57
1.4
1.5
—
—
—
0
0
(44790049)
22
107
2.07
2.57
1.4
1.5
—
—
—
0
0
(44806118)
22
107
2.07
2.57
1.4
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
43
261
1.67
2.56
2.1
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
39
231
1.71
2.54
1.5
1.2
—
17.3
—
0
13
(40768446) Kidney Pathology biopsy report
10
33
3.04
2.52
1.4
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
388
3368
1.20
2.51
2.9
2.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
19
88
2.17
2.51
1.6
1.3
u/l
11.0
13.8
0.47
19
82
(3002582) Erythrocytes [#/volume] in Urine
385
3341
1.20
2.50
4.0
3.4
e6/l
340.8
72.1
0.42
318
2615
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
466
4115
1.19
2.49
2.7
2.1
nmol/l
78.4
78.7
0.09
419
3591
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
258
1.65
2.40
1.5
1.6
iu/ml
0.0
0.2
—
10
49
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
64
2.36
2.39
1.1
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
33
190
1.75
2.38
3.0
4.3
%
1.2
1.4
0.13
20
152
(3021447) Carbon dioxide [Partial pressure] in Venous blood
132
1018
1.32
2.37
6.5
3.3
kpa
6.0
5.7
3.17
127
982
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
40
2.76
2.37
2.2
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
227
1881
1.24
2.32
1.3
1.2
u/ml
0.8
1.5
1.64
58
492
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
13
4.63
2.27
1.3
1.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
124
955
1.32
2.26
2.0
2.9
g/l
66.3
66.2
0.05
113
861
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
151
1197
1.29
2.24
1.5
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
301
2581
1.21
2.21
2.7
2.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
416
3676
1.18
2.18
3.1
3.3
mmol/l
2.4
2.3
0.09
361
3162
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
36
219
1.66
2.16
1.5
1.2
u/ml
10.2
12.9
—
6
39
(3000093) Morphology [Interpretation] in Blood Narrative
19
94
2.03
2.16
1.5
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
34
204
1.68
2.15
7.0
5.2
iu/ml
514.9
332.6
0.28
13
32
(3047181) Lactate [Moles/volume] in Blood
48
317
1.53
2.07
5.9
6.8
mmol/l
1.3
1.3
0.00
42
275
(3019150) Specific gravity of Urine by Refractometry
185
2233
0.80
2.06
5.2
4.2
kg/l
1.0
1.0
0.25
40
344
(3036782) Glucose [Moles/volume] in Pleural fluid
22
117
1.89
2.06
1.5
1.5
mmol/l
6.1
6.6
0.47
22
110
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
863
8086
1.15
2.05
9.7
7.3
u/l
78.6
81.6
1.27
824
7521
(3021960) Folate [Moles/volume] in Serum or Plasma
311
2693
1.19
2.05
1.6
1.6
nmol/l
18.6
20.3
1.40
263
2268
(3003181) Sodium [Moles/volume] in Urine
31
184
1.70
2.05
1.2
1.2
mmol/l
64.3
58.9
0.31
24
149
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
50
2.41
2.02
1.3
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
26
3.09
2.01
2.6
2.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
63
2.23
2.01
1.9
2.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1021
10698
0.86
1.99
27.5
18.0
mmol/l
4.0
4.0
1.14
990
10338
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
371
3270
1.18
1.99
2.7
2.1
u/l
173.1
230.6
0.98
343
3054
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
119
1.86
1.97
1.7
1.5
%
59.8
65.7
0.26
16
73
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
21
3.34
1.96
1.0
1.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
537
4876
1.16
1.96
7.8
5.8
mmol/l
1.2
1.2
0.00
480
4365
(3050794) Legionella sp Ab [Presence] in Serum
5
11
4.56
1.94
1.2
1.1
—
—
—
0
0
(4198724)
6
16
3.76
1.93
1.3
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
73
532
1.39
1.93
3.2
3.3
pmol/l
4.2
4.5
2.17
64
460
(3028707) Methadone [Presence] in Urine by Screen method
15
71
2.12
1.92
1.3
2.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
83
620
1.36
1.89
2.3
3.0
e9/l
4.2
4.1
0.17
57
460
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
677
6262
1.14
1.88
4.0
3.1
u/l
57.5
53.0
0.55
622
5767
(3019550) Sodium [Moles/volume] in Serum or Plasma
1020
10671
0.87
1.87
27.4
17.9
mmol/l
139.3
139.7
4.37
991
10324
(21494755) Public health laboratory ask at order entry panel
42
622
0.67
1.86
1.3
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
86
1.99
1.85
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
75
554
1.37
1.84
1.4
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
40
2.51
1.83
2.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
19
101
1.89
1.81
2.0
1.7
—
—
—
0
0
(4133840)
7
23
3.05
1.80
1.0
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
7
23
3.05
1.80
1.4
1.3
—
215.6
—
0
5
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
21
116
1.82
1.78
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
131
1.77
1.78
1.0
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
898
9461
0.88
1.78
6.8
6.0
mmol/mol
41.1
40.5
1.20
804
8614
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
109
1.85
1.77
2.0
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
504
4584
1.15
1.77
2.1
2.0
pmol/l
94.1
93.4
0.10
261
2398
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
177
1.65
1.76
2.4
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
43
290
1.50
1.73
1.5
3.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
127
1021
1.27
1.73
3.6
2.5
e9/l
68.4
67.2
0.15
99
795
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
24
2.92
1.72
1.4
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
227
1.55
1.68
1.4
1.2
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
6
19
3.17
1.66
2.5
3.1
—
29.1
—
0
5
(3028433) Virus identified in Specimen by Culture
8
31
2.59
1.66
1.1
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
341
3029
1.16
1.65
3.9
3.3
e6/l
0.6
0.5
0.09
268
2347
(3017143) Hepatitis C virus Ab [Presence] in Serum
109
866
1.28
1.64
1.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
70
925
0.74
1.64
5.3
3.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
11
49
2.25
1.63
1.3
1.1
u/l
30.2
30.7
—
6
35
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
11
49
2.25
1.63
1.3
1.1
u/l
87.2
75.8
—
6
37
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
121
975
1.26
1.63
1.5
1.5
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
14
3.58
1.61
1.2
2.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
164
1370
1.22
1.60
3.0
2.4
%
1.8
1.8
0.21
139
1200
(3014111) Lactate [Moles/volume] in Serum or Plasma
118
952
1.26
1.58
10.5
6.2
mmol/l
1.5
1.4
0.27
109
912
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
50
2.21
1.57
2.1
2.5
u/ml
497.5
1630.6
1.37
11
50
(3011436) Histone Ab [Units/volume] in Serum
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
15
3.34
1.52
1.2
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
141
1167
1.23
1.51
2.3
2.8
umol/l
7.8
10.4
0.93
119
1024
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
21
123
1.72
1.51
2.2
2.6
mg/l
13.3
23.0
—
7
34
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
21
2.86
1.50
1.5
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
65
2.01
1.48
2.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
33
219
1.52
1.46
1.3
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
10
45
2.23
1.46
2.2
1.6
mmol/l
7.7
11.0
—
10
35
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
785
7411
1.12
1.45
4.4
3.7
pmol/l
15.1
14.9
0.91
697
6585
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
117
1.72
1.45
1.3
1.2
u/ml
7.4
4.5
—
9
31
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
59
2.04
1.43
1.6
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
59
2.04
1.43
1.6
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
59
2.04
1.43
1.6
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
59
2.04
1.43
1.6
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
59
2.04
1.43
1.6
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
59
2.04
1.43
1.6
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
22
2.73
1.43
1.3
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
39
2.31
1.43
3.0
2.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
739
6965
1.12
1.39
5.9
4.7
e6/l
5195.6
2292.4
0.29
14
124
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
67
1.95
1.38
2.1
1.4
promille
1.4
0.8
—
7
51
(3003327) Ova and parasites identified in Stool by Light microscopy
36
247
1.47
1.38
1.5
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
52
382
1.37
1.38
1.7
3.7
ratio
1.0
1.8
—
5
32
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
158
1.59
1.38
1.4
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
120
0.41
1.37
1.2
2.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
422
3852
1.13
1.37
4.6
3.8
e6/l
65.7
132.7
1.71
339
2810
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
23
2.61
1.36
1.3
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
17
2.95
1.36
1.0
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
41
291
1.42
1.33
1.7
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
113
1.69
1.32
1.5
1.3
pmol/l
186.3
252.7
1.08
13
85
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
25
160
1.57
1.32
2.2
1.4
u/ml
120.6
142.2
—
7
30
(3001019) Free T4 and TSH panel - Serum or Plasma
19
307
0.61
1.31
2.0
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
759
7180
1.11
1.31
5.8
4.3
—
—
—
0
0
(3002256) Pathology report gross observation
159
1356
1.19
1.28
1.2
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
388
1.35
1.27
1.7
3.7
mg/l
139.3
70.9
0.27
32
320
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
388
1.35
1.27
1.7
3.7
mg/l
32.4
55.2
0.83
32
322
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
55
2.01
1.27
1.4
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
99
806
1.24
1.27
1.9
2.8
—
—
—
0
0
(4094501)
16
266
0.60
1.25
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
19
115
1.66
1.25
1.1
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
25
2.40
1.24
1.3
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
43
313
1.38
1.23
5.0
3.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
36
254
1.43
1.22
2.9
2.5
g/l
3.9
3.6
0.55
29
243
(3013637) Mi-2 Ab [Presence] in Serum
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
19
116
1.65
1.21
1.6
1.3
u/l
509.7
330.3
0.57
19
109
(3048879) Bone marrow aspiration report
8
37
2.17
1.21
1.7
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
63
488
1.30
1.21
1.5
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
180
1.51
1.21
1.4
1.4
u/l
10.0
10.4
0.04
19
141
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
148
1.56
1.20
1.5
1.2
u/ml
256.5
280.0
0.16
14
84
(3002173) Hemoglobin [Mass/volume] in Arterial blood
119
995
1.21
1.20
11.0
7.9
g/l
123.8
119.1
1.45
113
959
(40757373) Influenza virus identified in Isolate
6
26
2.31
1.18
1.3
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
117
1.63
1.18
3.0
3.8
%
59.1
52.9
—
9
83
(3016750) Collection duration of Urine
12
64
1.88
1.18
3.5
2.2
min
529.8
505.5
—
6
43
(3039443) Prostate specific Ag panel - Serum or Plasma
11
199
0.55
1.18
1.4
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
79
1.78
1.17
1.0
1.0
—
—
—
0
0
(4034850)
22
331
0.66
1.14
13.2
11.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
109
909
1.21
1.14
13.3
7.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
65
1.85
1.13
1.3
2.0
e6/l
845.8
756.7
—
6
29
(3023183) Ammonium ion [Moles/volume] in Plasma
34
242
1.41
1.12
4.8
3.1
umol/l
30.3
34.8
0.66
27
202
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
40
2.00
1.12
1.1
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
127
1.58
1.11
3.1
2.0
u/l
13817.3
823.0
—
8
45
(3021788) Differential panel - Synovial fluid
27
184
1.48
1.11
1.6
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
168
1461
1.17
1.10
9.1
5.3
mmol/l
1.0
1.0
0.15
155
1338
(3008295) Osmolality of Serum or Plasma
17
104
1.64
1.09
1.2
1.3
mosm/kgh2o
279.9
280.1
0.01
12
76
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
(4035726)
109
915
1.21
1.07
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
89
732
1.23
1.07
3.4
3.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
217
0.60
1.06
1.5
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
137
1.54
1.05
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
33
237
1.40
1.05
1.6
2.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
28
195
1.44
1.04
1.5
1.7
mu/l
238.7
282.9
0.54
23
175
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
159
1818
0.86
1.04
3.7
2.9
e6/l
1.3
1.1
0.22
97
1068
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
90
1.67
1.04
2.5
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
50
385
1.31
1.03
3.1
2.2
ug/l
303.8
584.9
1.06
45
362
(3044242) Glucose [Moles/volume] in Arterial blood
11
60
1.84
1.03
1.6
2.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
68
547
1.25
1.01
1.6
1.8
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
35
2.00
1.00
3.1
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
99
1.62
1.00
1.7
1.3
%
25.7
26.9
—
10
60
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
427
3970
1.10
0.98
4.2
3.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
321
2940
1.12
0.98
3.8
3.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
11
61
1.81
0.98
1.5
3.6
nmol/l
109.9
86.7
0.20
11
61
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
23
2.18
0.98
1.0
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
16
100
1.61
0.96
1.4
1.2
u/l
47.6
51.7
—
9
66
(3009508) Creatinine [Moles/volume] in Urine
354
3267
1.11
0.94
3.4
3.1
mmol/l
7.2
7.4
0.39
289
2671
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
37
277
1.34
0.94
1.2
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
17
109
1.57
0.93
1.5
2.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
513
4824
1.09
0.93
4.9
4.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
55
1.82
0.92
1.6
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
55
1.82
0.92
1.6
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
78
1.67
0.91
1.4
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
313
0.70
0.90
2.8
1.8
mg/l
6.2
3.1
0.64
16
233
(3004451) EKG impression Narrative
11
63
1.75
0.90
1.4
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
153
1732
0.87
0.89
3.9
3.1
e6/l
2.6
1.9
0.51
92
992
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
29
2.07
0.89
1.3
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
127
1.50
0.88
1.4
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
297
2726
1.11
0.88
5.1
4.2
estimate
0.0
0.0
0.69
148
860
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
111
954
1.18
0.88
1.8
1.8
%
1.5
1.5
0.04
93
822
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
11
64
1.72
0.86
1.3
1.2
—
85.0
—
0
6
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
44
1.82
0.86
1.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
12
72
1.67
0.85
1.3
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
137
1.47
0.84
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
531
5026
1.09
0.82
4.6
3.8
estimate
0.0
0.0
0.50
147
890
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
32
1.88
0.81
1.8
1.3
%
24.7
22.4
—
6
23
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
73
1.65
0.81
1.5
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
73
1.65
0.81
1.5
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
341
3166
1.10
0.81
3.4
3.2
mg/l
601.2
338.3
0.37
224
2006
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
81
1.61
0.81
2.8
2.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
69
574
1.21
0.79
2.7
2.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
139
1.44
0.79
1.9
1.5
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
24
0.00
0.79
0.0
1.2
—
1.1
—
0
18
(3016879) Cocaine [Presence] in Urine
22
156
1.42
0.79
1.3
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
165
1.40
0.77
1.3
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
3.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
20
140
1.43
0.77
1.5
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
99
1.52
0.75
5.9
3.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
53
1.70
0.75
1.0
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
405
1.24
0.75
5.0
2.6
u/ml
0.4
0.3
0.56
35
235
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
141
1.42
0.74
1.6
1.4
e6/l
78761.7
72040.0
0.04
13
79
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
24
2.09
0.74
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
136
1206
1.14
0.74
3.7
4.0
ug/l
6.4
23.0
1.45
110
987
(3028300) Cannabinoids [Presence] in Urine
23
167
1.38
0.73
1.3
1.8
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
38
1.85
0.73
3.0
2.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
408
3839
1.09
0.72
5.0
4.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
25
2.00
0.72
1.2
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
39
1.80
0.72
2.6
3.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
50
407
1.24
0.72
3.5
3.1
g/l
0.3
0.3
0.13
13
158
(3015183) Erythrocyte sedimentation rate
7
41
1.71
0.70
1.7
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
195
1.34
0.69
1.6
2.0
—
—
—
0
0
(3024471) HLA-A [Type]
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
27
1.85
0.68
1.6
1.3
%
173.6
173.8
—
5
27
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
43
1.63
0.67
1.1
1.1
iu/ml
1002.9
228.2
—
7
43
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
5
28
1.79
0.66
1.0
1.1
%
97.6
106.3
—
5
21
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
888
9129
0.93
0.65
5.5
4.5
mu/l
1.9
2.1
1.32
811
8147
(3045424) Erythrocytes [Presence] in Urine
21
154
1.37
0.65
1.2
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
34
269
1.27
0.64
3.5
2.4
ug/min
42.4
83.8
0.86
17
160
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
189
0.68
0.64
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
356
3350
1.08
0.64
4.5
3.9
mg/mmol
10.0
9.0
0.16
227
2122
(4306422)
16
112
1.43
0.63
1.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
267
2484
1.09
0.63
7.8
6.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
101
0.59
0.62
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
63
1.59
0.61
7.5
3.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
229
2118
1.10
0.61
3.0
3.1
mmol/l
2.5
2.5
2.56
198
1852
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
519
4961
1.07
0.61
4.6
3.8
estimate
0.0
0.0
0.00
158
913
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
35
433
0.80
0.60
4.0
3.0
u/ml
17.5
8988.5
0.81
29
375
(3021601) Nitrite [Presence] in Urine by Test strip
519
4964
1.07
0.59
6.2
5.1
estimate
0.0
0.0
0.00
158
926
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
427
1.20
0.59
1.9
2.9
g/l
2.8
3.1
1.39
41
326
(3036489) Thrombin time
41
336
1.23
0.59
2.6
2.1
s
20.7
21.3
0.47
34
308
(3027008) Opiates [Presence] in Urine
22
166
1.33
0.58
1.2
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
30
237
1.27
0.58
4.7
2.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
92
813
1.14
0.56
5.2
3.6
ng/l
105.2
93.5
0.61
75
696
(3032773) Endomysium IgG Ab [Titer] in Serum
11
73
1.51
0.56
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
65
1.54
0.55
1.7
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
13
90
1.45
0.55
3.7
2.3
ml
864.3
686.7
—
7
56
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
50
423
1.19
0.53
1.8
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
461
1.18
0.52
1.9
2.8
g/l
3.6
3.9
0.81
40
319
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
461
1.18
0.52
1.9
2.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
461
1.18
0.52
1.9
2.8
g/l
7.6
7.4
0.25
40
330
(40768800) Prostate Pathology biopsy report
21
271
0.77
0.52
1.3
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
63
1.43
0.52
12.9
17.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
70
611
1.15
0.52
1.3
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
63
546
1.16
0.51
18.3
10.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
40
1.50
0.51
1.7
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
126
1.35
0.51
3.3
4.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
44
374
1.18
0.46
1.1
1.1
titre
—
163.9
—
0
8
(3011648) Oxygen content in Venous blood
12
86
1.40
0.44
4.0
2.2
%
11.3
10.8
0.26
12
86
(3000475) Leukocytes [#/volume] in Synovial fluid
30
247
1.22
0.44
1.4
1.7
e6/l
10230.5
17797.9
0.95
25
175
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
105
954
1.11
0.44
2.2
2.4
u/l
29.4
39.6
1.32
84
804
(3027944) Amphetamines [Presence] in Urine
21
166
1.27
0.43
1.4
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
31
1.61
0.43
2.0
2.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
31
1.61
0.43
2.0
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
338
3225
1.06
0.43
3.5
3.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
113
1.33
0.42
2.7
2.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
56
1.43
0.42
2.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
91
0.66
0.42
1.2
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
32
1.56
0.42
1.0
1.1
—
23.6
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(4212803)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
16
0.00
0.41
0.0
9.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
114
1.32
0.40
1.1
1.2
u/ml
5.2
6.9
—
5
52
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
16
205
0.78
0.40
1.3
1.3
e6/l
11.7
47.7
0.63
11
164
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
77
692
1.12
0.40
2.0
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
69
770
0.89
0.39
2.2
2.2
nmol/l
12.7
12.3
0.12
61
674
(3037556) Urate [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
4.0
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
204
0.78
0.39
1.5
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
67
1.34
0.38
1.3
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
67
1.34
0.38
1.3
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
116
0.69
0.37
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
406
0.86
0.36
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
31
263
1.18
0.36
1.2
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
212
0.80
0.35
1.3
1.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
76
0.66
0.35
2.0
2.1
ug/l
2.6
2.0
—
5
65
(3045142) Bone marrow Pathology biopsy report
17
135
1.26
0.35
1.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
61
547
1.12
0.34
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
264
0.83
0.33
1.3
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
46
1.31
0.33
1.2
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
87
0.69
0.33
1.3
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
20
165
1.21
0.31
1.7
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
27
230
1.18
0.31
2.0
2.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
97
0.72
0.31
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
428
1.13
0.31
1.9
2.9
g/l
10.1
10.7
0.38
41
356
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
138
1.23
0.30
2.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
20
166
1.21
0.29
1.5
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
185
1.19
0.29
1.0
1.2
miu/ml
220.9
225.3
—
7
73
(3044290) Cell count panel - Cerebral spinal fluid
14
173
0.81
0.28
1.4
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
158
1.20
0.28
4.0
2.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
76
1.32
0.28
1.2
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
8
63
1.27
0.27
1.4
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
62
566
1.10
0.27
4.2
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1001
10132
0.96
0.27
26.6
15.0
mg/l
24.1
27.0
2.12
900
8053
(3002523) Influenza virus A Ag [Presence] in Specimen
14
113
1.24
0.26
1.1
1.1
—
—
—
0
0
(4024509)
12
95
1.26
0.26
1.5
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
72
1.25
0.25
1.6
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
85
911
0.93
0.25
1.5
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
12
96
1.25
0.24
2.0
2.1
—
1.2
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
9
77
1.17
0.24
3.9
2.5
%
13.4
13.2
—
9
77
(3050129) First trimester maternal screen panel - Serum or Plasma
6
83
0.72
0.24
2.0
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
716
7275
0.97
0.23
4.6
4.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
10
79
1.27
0.22
1.1
1.3
—
35.3
—
0
6
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
249
2574
0.96
0.22
1.6
1.6
mmol/l
1.5
1.3
1.20
185
2130
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
42
1.19
0.21
1.0
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
80
1.25
0.20
3.2
1.2
u/ml
—
—
—
0
0
(4268621)
10
80
1.25
0.20
2.1
2.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.9
—
65.4
—
0
14
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
25
221
1.13
0.20
1.4
1.8
iu/l
3.8
5.4
—
8
68
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
35
317
1.11
0.19
1.4
1.5
—
—
—
0
0
(4146454)
14
118
1.19
0.19
2.4
2.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
128
1.17
0.18
1.6
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
206
0.87
0.18
1.6
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
43
396
1.09
0.18
1.1
1.0
—
—
—
0
0
(4211845)
7
60
1.17
0.17
3.9
3.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
61
1.15
0.17
4.9
7.6
—
—
—
0
0
(3020891) Body temperature
47
436
1.08
0.17
5.6
4.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
74
782
0.94
0.17
3.0
2.8
ml/min/173m2
61.2
62.1
0.06
25
343
(42529406) Shigella sp [Presence] in Stool by Culture
26
288
0.90
0.16
1.0
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
172
1663
1.04
0.16
2.5
2.0
s
30.8
29.9
0.92
160
1610
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
71
1.13
0.16
1.6
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
71
672
1.06
0.15
1.1
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
77
0.78
0.15
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
245
0.90
0.15
1.4
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
93
1.18
0.14
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
141
1.14
0.13
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
97
0.82
0.13
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
56
529
1.06
0.13
2.6
2.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
284
0.91
0.13
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
325
0.92
0.13
5.7
4.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
113
1.15
0.13
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
94
1.17
0.13
1.7
1.6
—
—
—
0
0
(4281824)
9
106
0.85
0.13
1.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
262
0.91
0.12
5.8
3.5
mg/l
20.1
27.6
0.80
12
179
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
55
522
1.06
0.12
1.2
1.2
iu/ml
61.9
151.0
2.23
18
199
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
945
9502
0.99
0.09
22.6
14.4
ml/min/173m2
77.2
75.3
1.97
847
7858
(3008898) HLA-B27 [Presence]
26
242
1.08
0.09
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
155
1.10
0.09
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
54
1.11
0.09
4.2
3.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
57
1.05
0.08
1.3
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
65
0.77
0.08
1.6
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
6
73
0.82
0.07
1.2
2.1
—
116.9
—
0
15
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
75
1.07
0.07
1.4
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
8
76
1.05
0.07
1.3
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
122
0.90
0.07
1.4
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
285
0.95
0.06
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
128
1.09
0.06
1.6
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
138
1.09
0.06
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
58
564
1.03
0.05
1.7
1.7
g/l
1.6
1.5
0.15
49
476
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
109
1072
1.02
0.04
1.3
1.4
—
—
—
0
0
(1002224) Polysomnography panel
30
312
0.96
0.04
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
254
2562
0.99
0.04
1.5
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
13
121
1.07
0.03
2.2
2.0
u/field
1.3
2.3
—
6
37
(3019832) Treponema pallidum Ab [Presence] in Serum
47
458
1.03
0.03
1.6
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
266
2642
1.01
0.03
4.6
3.8
%
85.6
85.4
0.04
249
2572
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
34
349
0.97
0.02
2.2
2.7
g/l
38.6
37.4
0.58
29
292
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
123
1.06
0.01
1.1
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
132
1324
1.00
0.00
4.8
4.6
%
33.0
32.7
0.10
93
849
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
59
1.02
0.00
1.2
2.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
57.9
—
0
7
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.6
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
64
0.94
0.00
1.3
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
38.3
—
0
5
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
4.8
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
65.2
—
0
5
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
21.3
—
0
5
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
8.2
—
0
5
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
4.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
69
0.87
0.00
2.0
2.6
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint J10_BRONCHNAS and mortality.

Females

Parameter HR [95% CI] p-value
J10_BRONCHNAS 1.856 [1.65, 2.08] < 0.001
Birth year 0.995 [0.99, 1.0] 0.249

During the follow-up period (1.1.1998 — 31.12.2019), 1058 out of 2991 females with J10_BRONCHNAS died.

Males

Parameter HR [95% CI] p-value
J10_BRONCHNAS 2.101 [1.86, 2.37] < 0.001
Birth year 0.986 [0.98, 0.99] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1766 out of 3561 males with J10_BRONCHNAS died.

Mortality risk

Mortality risk for people of age

years, who have J10_BRONCHNAS.

N-year risk Females Males
1 0.175% 0.429%
5 0.997% 2.609%
10 2.501% 6.064%
15 5.092% 10.933%
20 8.903% 18.446%

Relationships between endpoints

↥

Index endpoint: J10_BRONCHNAS – Unspecified chronic bronchitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data